Dare Bioscience
DARE
DARE
30 hedge funds and large institutions have $5.82M invested in Dare Bioscience in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
55% less capital invested
Capital invested by funds: $12.8M → $5.82M (-$7.01M)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$46.6K | |
| 2 | +$20.6K | |
| 3 | +$8.6K | |
| 4 |
BlackRock
New York
|
+$7.47K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75K |
Top Sellers
| 1 | -$298K | |
| 2 | -$218K | |
| 3 | -$139K | |
| 4 |
Millennium Management
New York
|
-$48.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$26.6K |